Identifying Etiologies of Heart Failure Using Non-contrast Cardiac Magnetic Resonance Imaging: Cine Imaging, T1 and T2 Mapping, and Texture Analysis for T1 Mapping

Overview

Journal Front Cardiovasc Med

Date 2025 Feb 5

PMID 39906340

Authors

Yasuo Amano

Yasuyuki Suzuki

Xiaoyan Tang

Chisato Ando

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this retrospective study was to evaluate the usefulness of non-contrast cardiac magnetic resonance imaging, including cine imaging, T1 and T2 mapping, and texture analysis for T1 mapping, for identifying etiologies of heart failure (HF).

Methods: Forty-seven patients with HF were examined using a 1.5 T scanner. Cine imaging parameters and native T1 and T2 values at the mid-septal segment were measured. Vertical run length nonuniformity, vertical gray level nonuniformity (vGLNU), wavelet energy LL(3) and HH (4) on T1 mapping were estimated at the mid-septal segment using open-access software. Late gadolinium enhancement was investigated to help diagnose the etiologies of HF. We used Kruscal-Wallis' with a post-hoc Steel-Dwass' test, Wilcoxon signed-ranked test, Pearson's chai square test and receiver operator curve analysis (ROC) to assess the usefulness of non-contrast CMR for identifying etiologies of HF.

Results: There were significant differences in left ventricular end-diastolic volume (LVEDV) indexed to body surface area (LVEDVi), left ventricular myocardial mass/LVEDV, native T1, and vGLNU between dilated cardiomyopathy (DCM), hypertensive cardiomyopathy (HC) and tachycardia-induced cardiomyopathies (TIC). DCM had higher T1 and lower vGLNU than HC. When compared with TIC, DCM showed significantly higher LVEDV and LVEDVi. ROC analysis revealed that LVEDV and vGLNU provided high specificity for differentiating DCM from the other etiologies.

Conclusion: Native T1 mapping and its texture analysis may be valuable for differentiating between DCM and HC. Cine imaging can be useful for differentiating between DCM and TIC.

References

Emrich T, Hahn F, Fleischmann D, Halfmann M, Duber C, Varga-Szemes A . T1 and T2 mapping to detect chronic inflammation in cardiac magnetic resonance imaging in heart failure with reduced ejection fraction. ESC Heart Fail. 2020; 7(5):2544-2552. PMC: 7524213. DOI: 10.1002/ehf2.12830. View

Vera A, Cecconi A, Martinez-Vives P, Olivera M, Hernandez S, Lopez-Melgar B . Electrocardiogram and CMR to differentiate tachycardia-induced cardiomyopathy from dilated cardiomyopathy in patients admitted for heart failure. Heart Vessels. 2022; 37(11):1850-1858. DOI: 10.1007/s00380-022-02102-2. View

Mitropoulou P, Georgiopoulos G, Figliozzi S, Klettas D, Nicoli F, Masci P . Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance. Front Cardiovasc Med. 2020; 7:97. PMC: 7343712. DOI: 10.3389/fcvm.2020.00097. View

Mahrholdt H, Wagner A, Judd R, Sechtem U, Kim R . Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005; 26(15):1461-74. DOI: 10.1093/eurheartj/ehi258. View

Zhang T, An D, Zhou H, Chen B, Lu R, Fang W . Left Ventricular Vertical Run-Length Nonuniformity MRI Adds Prognostic Value to MACE in Patients with End-Stage Renal Disease. J Magn Reson Imaging. 2023; 59(2):522-532. DOI: 10.1002/jmri.28792. View

Baessler B, Mannil M, Maintz D, Alkadhi H, Manka R . Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results. Eur J Radiol. 2018; 102:61-67. DOI: 10.1016/j.ejrad.2018.03.013. View

Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2012; 48(3):452-8. PMC: 3590441. DOI: 10.1038/bmt.2012.244. View

Spieker M, Katsianos E, Gastl M, Behm P, Horn P, Jacoby C . T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2017; 19(5):574-582. DOI: 10.1093/ehjci/jex230. View

Badrish N, Sheifer S, Rosner C . Systems of care for ambulatory management of decompensated heart failure. Front Cardiovasc Med. 2024; 11:1350846. PMC: 10918851. DOI: 10.3389/fcvm.2024.1350846. View

10.

Bennett C, Qureshi Z, Sartor A, Norris L, Murday A, Xirasagar S . Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clin Kidney J. 2012; 5(1):82-88. PMC: 3341839. DOI: 10.1093/ckj/sfr172. View

11.

Baessler B, Luecke C, Lurz J, Klingel K, Das A, von Roeder M . Cardiac MRI and Texture Analysis of Myocardial T1 and T2 Maps in Myocarditis with Acute versus Chronic Symptoms of Heart Failure. Radiology. 2019; 292(3):608-617. DOI: 10.1148/radiol.2019190101. View

12.

Gulati A, Jabbour A, Ismail T, Guha K, Khwaja J, Raza S . Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013; 309(9):896-908. DOI: 10.1001/jama.2013.1363. View

13.

Takeda M, Amano Y, Tachi M, Tani H, Mizuno K, Kumita S . MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease. Jpn J Radiol. 2013; 31(10):693-700. DOI: 10.1007/s11604-013-0238-0. View

14.

Orlov O, Asfour A, Shchekochikhin D, Magomedova Z, Bogdanova A, Komarova A . Cardiac Magnetic Resonance in Patients with Suspected Tachycardia-Induced Cardiomyopathy: The Impact of Late Gadolinium Enhancement and Epicardial Fat Tissue. J Pers Med. 2023; 13(10). PMC: 10607955. DOI: 10.3390/jpm13101440. View

15.

McCrohon J, Moon J, Prasad S, McKenna W, Lorenz C, Coats A . Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003; 108(1):54-9. DOI: 10.1161/01.CIR.0000078641.19365.4C. View

16.

Ambrosy A, Fonarow G, Butler J, Chioncel O, Greene S, Vaduganathan M . The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014; 63(12):1123-1133. DOI: 10.1016/j.jacc.2013.11.053. View

17.

Haaf P, Garg P, Messroghli D, Broadbent D, Greenwood J, Plein S . Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016; 18(1):89. PMC: 5129251. DOI: 10.1186/s12968-016-0308-4. View

18.

Kasper E, Agema W, Hutchins G, Deckers J, Hare J, Baughman K . The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol. 1994; 23(3):586-90. DOI: 10.1016/0735-1097(94)90740-4. View

19.

Amano Y, Yanagisawa F, Omori Y, Suzuki Y, Ando C, Yamamoto H . Detection of Myocardial Tissue Alterations in Hypertrophic Cardiomyopathy Using Texture Analysis of T2-Weighted Short Inversion Time Inversion Recovery Magnetic Resonance Imaging. J Comput Assist Tomogr. 2020; 44(3):341-345. DOI: 10.1097/RCT.0000000000001007. View

20.

Szczypinski P, Strzelecki M, Materka A, Klepaczko A . MaZda--a software package for image texture analysis. Comput Methods Programs Biomed. 2008; 94(1):66-76. DOI: 10.1016/j.cmpb.2008.08.005. View